Xarelto and Nail ridging - a phase IV clinical study of FDA data

Summary:

Nail ridging is reported only by a few people who take Xarelto.

The phase IV clinical study analyzes which people take Xarelto and have Nail ridging. It is created by eHealthMe based on reports of 195,181 people who have side effects while taking Xarelto from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 01, 2023

195,181 people reported to have side effects when taking Xarelto.
Among them, 3 people (0.0%) have Nail ridging.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 197,108 Xarelto users for its effectiveness, alternative drugs and more.

What is Nail ridging?

Nail ridging (nail has raised ridges and is thin and curved inward) is found to be associated with 422 drugs and 280 conditions by eHealthMe.

Number of Xarelto and Nail ridging reports submitted per year:

Gender of people who have Nail ridging when taking Xarelto *:

female: 100 %
male: 0.0 %

Age of people who have Nail ridging when taking Xarelto *:

Common drugs people take besides Xarelto *:

Common side effects people have besides Nail ridging *:

Onychoclasis (breaking of the nails): 2 people, 66.67%
Weight Increased: 1 person, 33.33%
Pneumonia: 1 person, 33.33%
Pain In Extremity: 1 person, 33.33%
Onychalgia (nail biting): 1 person, 33.33%
Nail Pitting (small dents on the surface of your nails): 1 person, 33.33%
Insomnia (sleeplessness): 1 person, 33.33%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 1 person, 33.33%
Hair Loss: 1 person, 33.33%
Haemorrhagic Diathesis (bleeding tendency): 1 person, 33.33%

Common conditions people have *:

Rhinorrhea (watery mucus discharge from the nose): 1 person, 33.33%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 33.33%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 33.33%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 33.33%
High Blood Pressure: 1 person, 33.33%
Cardiac Disorder: 1 person, 33.33%
Asthma: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Xarelto and have Nail ridging?

Check whether Nail ridging is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Nail ridging and when was it recovered:

Nail ridging in Xarelto

Expand to all the drugs that have ingredients of rivaroxaban:

Nail ridging and drugs with ingredients of rivaroxaban

Alternative drugs to, pros and cons of Xarelto:

Xarelto (197,108 reports)

Common Xarelto side effects:

Nosebleed (bleeding from nose): 7,535 reports
Death: 6,147 reports
Breathing difficulty: 5,968 reports
Fatigue (feeling of tiredness): 5,818 reports

Browse all side effects of Xarelto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Nail ridging treatments and more:

Nail ridging (424 reports)

COVID vaccines that are related to Nail ridging:

All the drugs that are associated with Nail ridging:

Nail ridging (422 drugs)

All the conditions that are associated with Nail ridging:

Nail ridging (280 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Xarelto) and Xarelto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.